MWM
GSK icon

Moran Wealth Management’s GSK GSK Stock Holding History

Moran Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-425,646
Closed -$17.4M – 430
2024
Q3 		$17.4M Buy
425,646
+4,864
+1% +$199K 0.54% 61
2024
Q2 		$16.2M Buy
420,782
+64,566
+18% +$2.72M 0.53% 62
2024
Q1 		$15.3M Buy
356,216
+139,274
+64% +$5.74M 0.49% 69
2023
Q4 		$8.04M Buy
+216,942
New +$7.79M 0.29% 118

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Moran Wealth Management's GSK Position: Q4 2024 in Review

Moran Wealth Management sold out of GSK (GSK) in Q4 2024, closing a stake of 425,646 shares — an estimated $17.4M sold.

Moran Wealth Management first reported a position in GSK in Q4 2023 and held it in 4 quarters. The position peaked at $17.4M in Q3 2024. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Moran Wealth Management reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Moran Wealth Management sold 425,646 GSK shares in Q4 2024, an estimated $17.4M.
  • Moran Wealth Management first reported a position in GSK in Q4 2023 and held it in 4 quarters.
  • Moran Wealth Management's GSK position peaked at $17.4M in Q3 2024.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Moran Wealth Management's 13F filing for Q4 2024, filed 7 Feb 2025.